Pharma channel feed – Endpoints News

Pharma channel feed

Bayer plans label expansion for Kerendia after Phase 3 win in heart failure

10 months ago

Doses of Lilly's blockbuster GLP-1 in shortage have been pulled from FDA supply list

10 months ago

In Japan, sales of Eisai and Biogen's Alzheimer's drug begin to accelerate

10 months ago

Kyowa Kirin divests China unit, prunes discovery and manufacturing work

10 months ago

Agios' late-stage Pyrukynd trial in kids with rare blood disorder misses primary endpoint

10 months ago

Vertex says about 20 patients have started sickle cell therapy, cuts two rare disease programs

10 months ago

Vir's overhaul brings an end to most virology work — and a beginning with cancer

10 months ago

GSK scores expanded label for Jemperli in first-line endometrial cancer

10 months ago

Despite recent trial success, uniQure plans to cut 65% of staff

10 months ago

RSV market pressure leads to slower launch for Moderna's vaccine

10 months ago

Novartis sues FDA over approval of Entresto generic, following rejection of petition

10 months ago

Biogen CEO sees Alzheimer's drug on right path despite tiny sales, will keep biosimilars business

10 months ago

AbbVie closes $8.7B Cerevel deal in bid to compete with Bristol Myers in schizophrenia

10 months ago

US sales for Merck KGaA’s Bavencio impacted by Padcev/Keytruda momentum in bladder cancer

10 months ago

Updated: Eli Lilly’s tirzepatide reduces risk of heart failure outcomes in Phase 3 study

10 months ago

Judge rejects Novo Nordisk's IRA case as pricing negotiations conclude

10 months ago

Teva factored IRA's next round of negotiations into its growth plans

10 months ago

Takeda defends Alzheimer's pact, TYK2 potential as restructuring is in 'full swing'

10 months ago

Updated: Eisai says Alzheimer's drug keeps working after three years. But weaknesses in study raise questions

10 months ago

Updated: GSK unintimidated by RSV vaccine uptake challenges, Shingrix US sales drop

10 months ago

Takeda takes $140M hit on Phase 3 epilepsy flop, previews late-stage trials for pipeline prospects

10 months ago

Vertex gets January decision date for non-opioid pain medicine

10 months ago

After a year of tumult, Pfizer manages to pull off a boring quarter

10 months ago

FDA shoots down second Novartis petition seeking to halt Entresto generics

10 months ago

First page Previous page 43 44 454647 48 49 Next page Last page